Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

13.34 -0.32 (-2.34%)
Streaming Delayed Price Updated: 11:39 AM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
19 20 Next >
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
NOVOCURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
The Latest Analyst Ratings for NovoCure ↗
 
Via Benzinga
News headline image
Why NovoCure Stock Is Crashing Today ↗
Analysts weren't wowed by the company's late-stage data. 
Via The Motley Fool
News headline image
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into NovoCure Limited (NVCR)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon ↗
These three small cap drug companies could become gold or lead depending on the outcomes of their clinical trials. 
Via InvestorPlace
News headline image
This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street ↗
A big turnaround could be in the cards for this medical device maker. 
Via The Motley Fool
News headline image
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review ↗
The Nasdaq held near 52-week highs while small caps ramped up. 
Via Investor's Business Daily
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 29 companies set new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 ↗
 
Via Benzinga
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
These 2 Nasdaq Stocks Are Plunging. Here's Why ↗
Tuesday brought optimism to the stock market overall, but not for these companies. 
Via The Motley Fool
News headline image
Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher ↗
U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.36% to 33,440.78 while the NASDAQ rose 0.09% to 13,241.04. The S&P 500,... 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks Mixed As VIX Extends Lows ↗
Stocks are struggling for direction midday. 
Via Talk Markets
News headline image
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Edges Higher; Joann Shares Plummet ↗
U.S. stocks traded mixed midway through trading, with Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.08% to 33,534.50 while the NASDAQ rose 0.27% to 13,265.27. The S&P 500, also... 
Via Benzinga
News headline image
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. 
Via Benzinga
News headline image
Novocure Crashes Almost 30% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment ↗
Novocure said its device, Optune, extended overall survival by more than three months for some lung cancer patients. 
Via Investor's Business Daily
News headline image
Dow Drops 50 Points; J.M. Smucker Earnings Top Views ↗
U.S. stocks traded lower this morning, with Dow Jones dropping around 50 points on Monday. The Dow traded down 0.16% to 33,509.87 while the NASDAQ fell 0.19% to 13,203.91. The S&P 500, also fell,... 
Via Benzinga
News headline image
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Zai Lab Limited
Via GlobeNewswire
News headline image
LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Novocure
Via Business Wire
News headline image
Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education
From Novocure
Via Business Wire
News headline image
3 No-Brainer Stocks to Buy for Under $100 Right Now ↗
These stocks might not remain under $100 for too much longer. 
Via The Motley Fool
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.